Cancer Res (2024) 84 (6_Supplement): 48. Introduction: Multiple Myeloma (MM) is the second most diagnosed hematologic malignancy and remains an incurable disease. KLN-1010 is a novel treatment for MM ...

Cancer Res (2024) 84 (7_Supplement): LB055.

Cancer Res (2007) 67 (9_Supplement): 5388.

Cancer Res (2023) 83 (8_Supplement): LB031.

1USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. 2Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los ...

1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...

1School of Medicine, University of California San Diego, La Jolla, California. *Corresponding Author: James T. Robinson, School of Medicine, University of California ...

1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, ...

1Genentech, Inc., South San Francisco, CA. Search for other works by this author on: ...

1Department of Cell Growth and Tumor Regulation, Proteo-Science Center, Ehime University, Toon, Japan. Search for other works by this author on: 2Laboratory of Molecular Pharmacology & Developmental ...

Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.